Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001683168-19-003350
Filing Date
2019-10-23
Accepted
2019-10-23 16:50:02
Documents
44
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K odyssey_10k-073119.htm 10-K 424846
2 CERTIFICATION odyssey_ex3101.htm EX-31.1 7386
3 CERTIFICATION odyssey_ex3201.htm EX-32.1 3194
4 CODE OF ETHICS odyssey_ex014.htm EX-99.2R CODE ETH 18164
  Complete submission text file 0001683168-19-003350.txt   1585046

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE odyy-20190731.xml EX-101.INS 126935
6 XBRL SCHEMA FILE odyy-20190731.xsd EX-101.SCH 20957
7 XBRL CALCULATION FILE odyy-20190731_cal.xml EX-101.CAL 28460
8 XBRL DEFINITION FILE odyy-20190731_def.xml EX-101.DEF 59781
9 XBRL LABEL FILE odyy-20190731_lab.xml EX-101.LAB 143778
10 XBRL PRESENTATION FILE odyy-20190731_pre.xml EX-101.PRE 117243
Mailing Address 2372 MORSE AVE. IRVINE CA 92614
Business Address 2372 MORSE AVE. IRVINE CA 92614 702-751-1418
Odyssey Group International, Inc. (Filer) CIK: 0001626644 (see all company filings)

EIN.: 471022125 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-K | Act: 34 | File No.: 333-200785 | Film No.: 191164253
SIC: 2833 Medicinal Chemicals & Botanical Products